From Don_Gregory@MSI.COM  Sun Jun 12 12:25:25 1994
Received: from schizoid.msi.com  for Don_Gregory@MSI.COM
	by www.ccl.net (8.6.4/930601.1506) id LAA28175; Sun, 12 Jun 1994 11:50:56 -0400
Received: from msi.com (qmail-gw.msi.com) by schizoid.msi.com (4.1/SMI-4.1)
	id AA13346; Sun, 12 Jun 94 11:50:27 EDT
Message-Id: <9406121550.AA13346@schizoid.msi.com>
Date: 12 Jun 1994 11:50:37 +0000
From: "Don Gregory" <Don_Gregory@MSI.COM>
Subject: Polymorph Prediction Semina
To: "OSC  BBS" <chemistry@ccl.net>


                       Subject:                               Time:11:34 AM
  OFFICE MEMO          Polymorph Prediction Seminars          Date:6/12/94
Seminar Series Announcement!

Announcing a free seminar series for Polymorph Prediction.
Polymorphism related problems are commonly encountered in:
Pharmaceuticals,  Agrochemicals,  Pigments,  Dyes,  Specialty chemicals, 
Explosives, and other formulation technologies.
Today, companies are encountering problems related to polymorphism, while
others are exploiting the patent extension opportunities offered by
polymorphism.  Numerous crucial physico-chemical properties may vary
dramatically among polymorphs:  product stability, shelf life, vapor pressure,
melting point, solubility, bioavailability, morphology, compressibility,
density, shock sensitivity, detonation velocity and detonation pressure.

During this free half-day seminar series, speakers will present, discuss, and
demonstrate C2oPolymorph in the Cerius2 environment, an exciting and innovative
technique to predict possible polymorphs of fairly rigid molecules from
scratch.  This novel Computational Instrument promises to be a break-through in
a controversial area.  In conjunction with other Cerius2 modules from the
C2oCrystal Growth Workbench, C2oPolymorph is an extremely powerful tool to
solve polymorphism related problems.

Coupling MSI's state-of-the-art modeling environment with the computational
speed of Hewlett Packard's PA-RISC 7150 micro-processor, Hewlett Packard and
MSI offer a complete solution that is fast, affordable, and easy to use.  The
series 700 model 735 workstation with the 7150 microprocessor running on 125mhz
with performance up to 154MIPS, is ideal for compute intensive and demanding
graphics applications.
To register for any of the following seminars, call Molecular Simulations Inc.
at (617) 229-9800, extension 567 in the U.S.  In Europe, call +44 223 413302,
extension 31.

POLYMORPH PREDICTION SEMINAR SERIES IN EUROPE
Monday, 4 July
London, England

Tuesday, 5 July
Brussels, Belgium

Wednesday, 6 July
Frankfurt, Germany

Thursday, 7 July
Basel, Switzerland
============
POLYMORPH PREDICTION SEMINAR SERIES IN THE U.S.
Tuesday, July 12
Research Triangle Park, NC

Wednesday, July 13
Valley Forge, PA

Thursday, July 14
Saddle Brook, NJ

Friday, July 15
Indianapolis, IN

============

THE AGENDA
8:30am	     Registration and Continental Breakfast


9:00am	     "The Commercial Impact of Polymorphism"
		Dr. Frank J.J. Leusen, MSI
 	     
	       
9:30am      "The Novel Approach to Polymorph Prediction"
		Dr. Heinrich R. Karfunkel
		

10:30am   Coffee Break

	      
11:00am      "Cerius2 for Polymorph Prediction"
		Drs. Frank J.J. Leusen 
		and Mark R.S. Pinches
		
	
11:30am      Cerius2 Product Demonstrations
		Dr. Mark R.S. Pinches


12:15pm     "Industrial Applications of C2oPolymorph"
		Dr. Stephen J. Maginn 
		
	
1:00pm        Close of  Seminar   


THE SPEAKERS
DR. HEINRICH R. KARFUNKEL  --   Dr. Karfunkel joined Ciba Geigy in Basel,
Switzerland, as group leader of central research molecular modeling in 1986 and
is now responsible for the transfer of new computational chemistry techniques
to Ciba Geigy world-wide.  He studied Chemistry, Biochemistry and Mathematics,
and received his Ph.D. in Theoretical Chemistry 
from Tuebingen University, Germany, where he still lectures.  Dr. Karfunkel's
current research interests include polymorph prediction, QSPR, materials
design, and protein folding.

Dr. Mark R.S. Pinches  --   Dr. Pinches is a member of the materials science
development team and has implemented the innovative C2.Polymorph module in the
Cerius2 environment.  He received his Ph.D. in Chemical Physics from
Southampton University, UK, under the direction of Prof. Tildesley.  Before
joining Molecular Simulations, Dr. Pinches worked at the Parallel Applications
Centre of Southampton University.

Dr. Frank J.J. Leusen --   Dr. Leusen is Molecular Simulations' Crystal Growth
and Particulate Technology Products Manager.  He holds a M.Sc. degree in
Pharmacy from Leiden University and a Ph.D. in Chemistry from Nijmegen
University, The Netherlands, where he applied molecular modeling to study the
crystallization behavior of organic salts.  Since 1989, Dr. Leusen has acted as
an industrial consultant to Ciba Geigy, Switzerland.

Dr. Stephen J. Maginn  --  Dr. Maginn joined Molecular Simulations in June 1993
as Senior Applications Scientist after working for ICI/Zeneca's Corporate
Crystal Chemistry Team for four years, studying solid state problems throughout
the companies' product base.  He received his Ph.D. in Chemistry from Liverpool
University, UK.

To register for any of the following seminars, call Molecular Simulations Inc.
at (617) 229-9800, extension 567 in the U.S.  In Europe, call +44 223 413302,
extension 31.




From Don_Gregory@MSI.COM  Sun Jun 12 12:40:42 1994
Received: from schizoid.msi.com  for Don_Gregory@MSI.COM
	by www.ccl.net (8.6.4/930601.1506) id MAA28265; Sun, 12 Jun 1994 12:15:19 -0400
Received: from msi.com (qmail-gw.msi.com) by schizoid.msi.com (4.1/SMI-4.1)
	id AA13403; Sun, 12 Jun 94 12:14:53 EDT
Message-Id: <9406121614.AA13403@schizoid.msi.com>
Date: 12 Jun 1994 12:18:51 +0000
From: "Don Gregory" <Don_Gregory@MSI.COM>
Subject: Drug Design Seminar Serius
To: "OSC BBS" <chemistry@ccl.net>


                       Subject:                               Time:10:00 AM
  OFFICE MEMO          Drug Design Seminar Serius             Date:6/10/94
Seminar Announcements!

Announcing a free scientific seminar series presented by Molecular Simulations
Inc. (MSI) and Hewlett Packard.  Speakers for this program will discuss
innovative scientific methods for structure activity analysis  to enable users
to increase the efficiency of the lead optimization and lead generation cycle
in your organisation..  Topics will include:
 
	o  Pharmacophore model generation 
	o  Database search strategies
	o  Advanced QSAR techniques 
	o  Computer-aided compound selection 
	o  Molecular similarity
	o  Pseudo-receptor model generation

Coupling MSI's state-of-the-art modelling environment with the computational
speed of Hewlett Packard's PA-RISC 7150 micro-processor, Hewlett Packard and
MSI offer a complete solution that is fast, affordable, and easy to use.  The
series 700 model 735 workstation with the 7150 microprocessor running on 125mhz
with performance up to 154MIPS, is ideal for compute intensive and demanding
graphics applications.

To register for any of the following seminars, call Molecular Simulations Inc.
at (617) 229-9800, extension 567 in the U.S.  In Europe, call +44 223 413302,
extension 31.

MOLECULAR SIMULATIONS INC. AND HEWLETT PACKARD PRESENT:

STRATEGIES IN DRUG DISCOVERY SEMINAR SERIES IN THE U.S.
Monday, July 18
Cambridge, MA

Tuesday, July 19
New Brunswick, NJ

Wednesday, July 20
Research Triangle Park, NC

Thursday, July 21
La Jolla, CA

Friday, July 22
Burlingame, CA
(San Francisco Airport area)

THE AGENDA
8:00am	       Registration and Continental Breakfast

8:30am	      Introduction and Welcome
	    	 		
8:45am        Dr. Anthony Hopfinger, University of Illinois
 	           	"Strategies for the Construction of 
	           	  3D QSARs Based upon Molecular 
	           	  Shape Analysis"

	       
9:30am        Dr. David Rogers, Molecular Simulations Inc.
	             	"QSAR Analysis using Genetic Algorithms"
	        	  
10:15am     Product Demonstration

10:30am       Coffee Break

10:45am       Dr. Peter Sprague, BioCAD Corporation
		               "Structure Activity Analysis with Catalyst: 
		                  Conversion of Peptide Lead Information into 
                     Non-peptide Drug Candidates"

11:30am        Dr. Simon Kearsley, Merck Research Laboratories
	                	"Computer-Aided Compound Selection Techniques"

12:15pm       Product Demonstration

=================================

STRATEGIES IN DRUG DISCOVERY SEMINAR SERIES IN EUROPE
Tuesday, 28 June
Stockholm, Sweden

Wednesday, 29 June
Paris, France

Thursday, 30 June
Frankfurt, Germany

Friday, 1 July
London, England

AGENDA
9:30am	       Registration and Coffee

10:00am	      Introduction and Welcome
		
10:15am       Dr. Anthony Hopfinger, University of Illinois
 	           	"Strategies for the Construction of 
	            	  3D QSARs Based upon Molecular 
		              Shape Analysis"

11:00am        Dr. David Rogers, Molecular Simulations Inc.
	               	"QSAR Analysis using Genetic Algorithms"
		 	 
11:45pm     Product Demonstration
	      
12:00pm       Lunch
	
13:00pm       Dr. Peter Sprague, BioCAD Corporation
		"Structure Activity Analysis with Catalyst: 
		  Conversion of Peptide Lead Information into 
     Non-peptide Drug Candidates"

14:00pm        Dr. Simon Kearsley, Merck Research Laboratories
		"Computer-Aided Compound Selection Techniques"


15:00pm        Product Demonstration

THE SPEAKERS
Dr. Anthony Hopfinger  -  Dr. Hopfinger is Professor of Medicinal Chemistry,
Chemistry and Chemical Engineering at the University of Illinois at Chicago. 
He received  his Ph.D. from Case Western Reserve University, and was an NIH
post-doctoral fellow at Harvard Medical School.  Following post-doctoral
studies, Dr. Hopfinger was a member of the faculty at Case Western Reserve
University.  In 1981 he joined G.D. Searle and Company as Director of Medicinal
Chemistry, and in 1985 he took up his current position.   Professor Hopfinger
has over 185 publications including three books, and is co-founder of three
companies focused on computational chemistry software and biotechnology.

Dr. Peter W. Sprague  -  Dr. Sprague was educated (BS, PhD) in synthetic
organic chemistry at Case-Western Reserve University and held acadmic positions
at Indiana Universityand California State University at San Bernardino.  He
joined Bristol-Myers Squibb in 1972 and was involved with various medicinal
chemistry projects including ACE inhibition and Thromboxane Antagonism until
leaving in 1991 to join BioCAD Corporation where he currently holds the
position of Vice President for Support. 

Dr. Simon Kearsley  -  Dr. Kearsley is currently  a Senior Research Fellow at
Merck Research Laboratories in charge of developing scientific computing
methodology relevant to drug design.  He earned his Ph.D. in Physical Chemistry
from Cam-bridge University in England working with Professor Thomas.  Dr.
Kearsley also did post-doctoral work at Yale University with Professors McBride
and Prestegard.   

Dr. David Rogers  -  Dr. Rogers joined MSI in 1991, and is currently leading
the development of several applications based upon Genetic Algorithms.  He
earned his doctorate work-ing with Professor W. Todd Wipke at UC-Santa Cruz,
followed by post-doctoral appointments at the MIT Artificial Intelligence Lab
and the University of Michigan Cognitive Science Lab.  Dr. Rogers has since
published on a wide range of topics, including compu-tational chemistry, neural
networks, statistics, brain research, and genetic algorithms.

To register for any of the following seminars, call Molecular Simulations Inc.
at (617) 229-9800, extension 567 in the U.S.  In Europe, call +44 223 413302,
extension 31.




From NETNEWS@UICVM.CC.UIC.EDU  Sun Jun 12 16:25:28 1994
Received: from phem3  for NETNEWS@UICVM.CC.UIC.EDU
	by www.ccl.net (8.6.4/930601.1506) id PAA02345; Sun, 12 Jun 1994 15:25:41 -0400
Received: from UICVM.CC.UIC.EDU (MAILER@UICVM) by phem3.acs.ohio-state.edu
 (PMDF V4.2-13 #5888) id <01HDGJWNMXTS8Y54K6@phem3.acs.ohio-state.edu>; Sun,
 12 Jun 1994 15:25:25 EDT
Received: from UICVM.UIC.EDU (NJE origin NETNEWS@UICVM) by UICVM.CC.UIC.EDU
 (LMail V1.2a/1.8a) with BSMTP id 8754; Sun, 12 Jun 1994 14:24:51 -0500
Date: Sun, 12 Jun 1994 14:24:41 -0500 (CDT)
From: the X-Man <U51141@uicvm.uic.edu>
Subject: WANTED HP Temperature Station
Sender: NETNEWS@UICVM.UIC.EDU
To: CHEMISTRY@ccl.net
Message-id: <94163.142441U51141@uicvm.uic.edu>
Organization: University of Illinois at Chicago, ADN Computer Center
Content-transfer-encoding: 7BIT
Path: uicvm.uic.edu!u51141
Newsgroups: sci.research,misc.wanted,chi.wanted,bit.listserv.chemistry
Lines: 41


 
To those who can offer assistance:
 
I am in URGENT need to replace the following piece of equipment which I
currently use in conducting my research, and which has,since it's original
purchase become obsolete by it's manufacturer Hewlett-Packard
 
The following is needed:
 
a Hewlett-Packard 89101A (new model #89101-60001) Temperature Station
 
description:
 
The HP 89101A is an adjustable temperature controlled cuvette holder for
standard 1.0 cm cuvettes and flow cells. It is operated in conjunction
with an HP 89100A Temperature Controller and the combined unit provides
temperature-controlled experimentations to be performed on a Hewlett-Packard
8450A UV/Vis Spectrophotometer.
 
The item sought (HP 89101A or HP 89101-60001) Temperature Station has stirring
capabilities, a side access window to accommodate flow cells with side-
mounted suction outlets, provisions for gas purging to reduce condensation
on the surface of the cuvette, and water cooling for sub-ambient operations
 
*** If anyone receiving this posting can provide me with the
    actual unit (for purchase), information as to where i might be
    able to obtain one (as HP has made the entire unit-spectrophotometer,
    temperature controller, and temperature station obsolete-and thusfar
    communications with HP have resulted in the company stating that
    they do have 2 such units available but their asking price
    has doubled since HP has discontinued this model of device), or
    can provide me with any information whatsoever, please
    contact me as soon as possible at the following e-mail address
 
email address: internet:  U51141@uicvm.uic.edu
               bitnet:    U51141@uicvm.BITNET
 
 
Your assistance in this matter is greatly appreciated.
 
Joe Hilario

